I don't know anything about this particular filing, but the FDA is primarily concerned with you having demonstrated safety and efficacy.
For this reason, I would suspect the new reports will not include anything that they could not provide scientific evidence for effective differentiation, as well as anything without convincing argument that a report would not increase workup rates, etc. with some inherent risk.
There have always been partners you can get the entire suite of results from.[1] I don't know how they haven't been restricted, but my guess is the FDA can't ban telling you what a SNP does, but the FDA can ban 23 and me selling it as a service connected somehow? Anyways, you can find out everything you wanted to know and a million other things you probably will have trouble of fully understanding.
For this reason, I would suspect the new reports will not include anything that they could not provide scientific evidence for effective differentiation, as well as anything without convincing argument that a report would not increase workup rates, etc. with some inherent risk.